In Cohort 2, serum IgA and ALS IgG responses to LPS were more frequent in naïve subjects (both 94.7%) than rechallenged veteran subjects (55.6% and 30.0%, respectively) despite comparable baseline titers (both p = 0.04) (Fig 5A). This evidence concerns the gene CD79A and amyotrophic lateral sclerosis.